As of November 2024, Karyopharm Therapeutics has a market cap of $84.41M. This makes Karyopharm Therapeutics the world's 22160th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $150.61M | 52.02% |
2023 | $99.07M | -74.56% |
2022 | $389.42M | -47.12% |
2021 | $736.45M | -58.46% |
2020 | $1.77B | -19.25% |
2019 | $2.20B | 104.59% |
2018 | $1.07B | -2.40% |
2017 | $1.10B | 2.13% |
2016 | $1.08B | -29.06% |
2015 | $1.52B | -64.60% |
2014 | $4.29B | 63.31% |
2013 | $2.63B | - |